CE vs SPRO · rev $10.28B vs P/E 9.6, rev $48.0M
Celanese Corporation (CE) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
CE currently screens at market cap $5.92B. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the CE and SPRO stock pages for the full models.
Not investment advice.